Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Kuros Biosciences AG (KURN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7486
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products are being developed for spinal fusion, fracture repair and as surgical sealants. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. Kuros Biosciences is headquartered in Schlieren, Switzerland.

Kuros Biosciences AG (KURN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kuros Biosciences AG, Medical Equipment, Deal Details 10
Venture Financing 10
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Merger 13
Cytos Biotech Merges with Kuros Biosurgery 13
Equity Offering 14
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 14
Kuros Biosciences Raises Funds through Rights Offering of Shares 15
Kuros Biosciences Raises Funds through Public Offering of Shares 16
Acquisition 17
Kuros Biosciences Acquires Xpand Biotech 17
Kuros Biosciences AG – Key Competitors 18
Kuros Biosciences AG – Key Employees 19
Kuros Biosciences AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Sep 05, 2018: Kuros Biosciences announces results for first half 2018 21
Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results 22
Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016 23
Corporate Communications 25
Aug 23, 2018: Kuros Biosciences names Pascal Longlade as chief medical officer 25
May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM 26
Dec 14, 2017: Kuros Biosciences Announces Management Succession 27
Nov 28, 2017: Kuros Biosciences’ Chief Medical Officer to Retire 28
Nov 16, 2017: Kuros announces management changes 29
Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members 30
Apr 13, 2017: Kuros announces CEO succession 31
Legal and Regulatory 32
Feb 08, 2017: Kuros achieves ISO certification for surgical sealants 32
Product News 33
Mar 12, 2018: Kuros Biosciences obtains European patent covering osteoinductive materials 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Kuros Biosciences AG, Medical Equipment, Key Facts, 2017 2
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Deals By Market, 2012 to YTD 2018 8
Kuros Biosciences AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Cytos Biotech Merges with Kuros Biosurgery 13
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 14
Kuros Biosciences Raises Funds through Rights Offering of Shares 15
Kuros Biosciences Raises Funds through Public Offering of Shares 16
Kuros Biosciences Acquires Xpand Biotech 17
Kuros Biosciences AG, Key Competitors 18
Kuros Biosciences AG, Key Employees 19
Kuros Biosciences AG, Subsidiaries 20

List of Figures
Kuros Biosciences AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kuros Biosciences AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kuros Biosciences AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kuros Biosciences AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kuros Biosciences AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The TJX Companies, Inc.:企業の戦略・SWOT・財務情報
    The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • John Menzies Plc:企業の戦略・SWOT・財務分析
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務情報
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Celgene Corporation:企業のM&A・事業提携・投資動向
    Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Teco Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …
  • CEDA International Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary CEDA International Corp (CEDA) is an oil and gas company that offers energy services. The company provides services such as turnaround, industrial maintenance, electrical services, exchanger services, hydro-testing and pipe isolation services, and construction services, among others. It also …
  • Ivenix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ivenix Inc (Ivenix), formerly Fluidnet Corp is a medical technology company that offers infusion therapy solutions. The company offers products such as IV smart pumps and intravenous drug infusion pump systems. Its IV smart pumps eliminate air from fluid bag and IV lines to reduce number of …
  • Pure Bioscience Inc (PURE)-製薬・医療分野:企業M&A・提携分析
    Summary Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. It develops and markets proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen an …
  • Schneider Electric SE (SU)-石油・ガス分野:企業M&A・提携分析
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line comprises automation and control products, building management and securi …
  • RWE AG:発電所・企業SWOT分析
    RWE AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Territorial Generating Company #2 (TGKB):企業の財務・戦略的SWOT分析
    Territorial Generating Company #2 (TGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Banco de Sabadell SA:企業のM&A・事業提携・投資動向
    Banco de Sabadell SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco de Sabadell SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Protalex Inc (PRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops and offers drugs for autoimmune and inflammatory diseases. The company’s product includes PRTX-100, a formulation of staphylococcal protein A, which is an immune modulating protein produced by Staphylococcus aureus bacteria …
  • Nordic American Tankers Ltd (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • NTT Communications Corporation:企業の戦略・SWOT・財務情報
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mexco Energy Corp (MXC):石油・ガス:M&Aディール及び事業提携情報
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆